The study drug is a potential new treatment for obesity and preventing regain of weight
The study is exploring an investigational treatment to address the growing health issues related to being overweight and obese, which are linked to various long-term diseases. These conditions can lead to serious health problems, including heart diseases and metabolic disorders, making it important to find new treatment options.
The study medication is being tested to determine its safety, tolerability, pharmacokinetics (what the body does to the drug), and pharmacodynamics (what the drug does to the body) in healthy overweight or obese individuals. While approved drugs can achieve weight loss, they are associated with a high incidence of stomach and gut-type side effects. This study provides the opportunity for the development of a new drug that may promote greater weight loss with fewer side effects.
Your participation could be key to advancing medical research and bringing new hope to patients worldwide.
Call us at 1300 109 508 to discuss your eligibility today!